Sclerosing cholangitis, race and sex

Gut

Volumn 41, Issue 5, 1997, Pages 688-689

  Kelly, P ^a   Patchett, S ^a   McCloskey, D ^b   Alstead, E ^a   Farthing, M ^a   Fairclough, P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Genetics of inflammatory bowel disease; Racial effects on disease; Sclerosing cholangitis; Ulcerative colitis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AFRICA; ARTICLE; CARIBBEAN ISLANDS; CLINICAL ARTICLE; EUROPE; FEMALE; GENDER; HUMAN; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; ULCERATIVE COLITIS;

EID: 0030661748     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.5.688     Document Type: Article

References (10)

1. Segal I. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int J Colored Dis 1988; 3: 222-5.
2. O'Donoghue DP, Clark ML. Inflammatory bowel disease in West Indians. BMJ 1976; ii: 796.
3. Benfield G, Asquith P. Ulcerative colitis in West Indian immigrants. Q J Med 1986; 229: 489-95.
4. Garland CF, Lilienfeld AM, Mendeloff AI, Markowitz JA, Terrell KB, Garland FC. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology 1981; 81: 1115-24.
5. Simsek H, Schuman BM. Inflammatory bowel disease in 64 black patients: analysis of course, complications and surgery. J Clin Gastroenterol 1989; 11: 294-8.
6. Chapman RW. Aetiology and natural history of primary sclerosing cholangitis - a decade of progress? Gut 1991; 32: 1433-5.
7. Lee YM, Kaplan M. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.
8. Mehal WZ, Lo YM, Wordsworth BP, Neuberger JM, Hubscher SC, Flemming KA, et al. HLA-DR4 is a marker for rapid disease progression in PSC. Gastroenterology 1994; 106: 160-7.
9. Snook JA, Chapman RW, Fleming K, Jewell DP. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease, and primary sclerosing cholangitis. Clin Exp Immunol 1989; 76: 30-3.
10. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331-8.